Live News Categoriesmarket

NSRX.A (NSRX.A) News

Track canonical SquawkNews coverage tagged to NSRX.A, NSRX.A. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol NSRX.A Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 12:04 PM UTC Open live news feed

M Nasus Pharma enrolls first patient in Phase 1 trial of intranasal ondansetron candidate NS003 Nasus Pharma enrolled and dosed the first patient in a Phase 1 trial of NS003, an intranasal ondansetron formulation, with first-in-human pharmacokinetic and safety readouts expected before year-end. EQUITY | Sep 29, 2026, 12:04 PM UTC